We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Lazard
LAZ
$4.21B
| $449K | ﹤0.01% |
10,319
-173,958
| -94% | -$7.4M |
|
1977
MVB Financial
MVBF
$383M
| $449K | ﹤0.01% |
+13,289
| New | +$372K |
|
1978
Ambarella
AMBA
$3.03B
| $445K | ﹤0.01% |
+4,434
| New | +$483K |
|
|
YDKG
1979
Yueda Digital Holding
YDKG
$5.25M
| $445K | ﹤0.01% |
+325
| New | +$447K |
|
1980
Cibus
CBUS
$148M
| $444K | ﹤0.01% |
+1,476
| New | +$609K |
|
1981
AdvisorShares Pure US Cannabis ETF
MSOS
$830M
| $444K | ﹤0.01% |
+10,477
| New | +$483K |
|
1982
Smith & Nephew
SNN
$13.7B
| $444K | ﹤0.01% |
+11,737
| New | +$485K |
|
|
MTACU
1983
DELISTED
MedTech Acquisition Corporation Unit
MTACU
| $444K | ﹤0.01% |
+44,184
| New | +$470K |
|
1984
SELLAS Life Sciences
SLS
$1.98B
| $443K | ﹤0.01% |
+51,861
| New | +$424K |
|
1985
VYNE Therapeutics
VYNE
$19.1M
| $442K | ﹤0.01% |
+72
| New | +$522K |
|
|
B
1986
DELISTED
Barnes Group Inc.
B
| $441K | ﹤0.01% |
+8,899
| New | +$467K |
|
1987
Ameresco
AMRC
$1.04B
| $438K | ﹤0.01% |
+9,009
| New | +$496K |
|
1988
Arista Networks
ANET
$214B
| $438K | ﹤0.01% |
+23,232
| New | +$434K |
|
1989
Barings BDC
BBDC
$885M
| $436K | ﹤0.01% |
+43,736
| New | +$416K |
|
|
GOOS
1990
Canada Goose Holdings
GOOS
$903M
| $436K | ﹤0.01% |
11,098
-110,259
| -91% | -$4.36M |
|
1991
F5
FFIV
$22.8B
| $434K | ﹤0.01% |
+2,081
| New | +$410K |
|
1992
Rithm Capital
RITM
$5.46B
| $432K | ﹤0.01% |
38,368
-652
| -2% | -$6.63K |
|
1993
WD-40
WDFC
$3.08B
| $430K | ﹤0.01% |
1,404
+164
| +13% | +$49.7K |
|
1994
Rogers Communications
RCI
$18.8B
| $428K | ﹤0.01% |
9,282
-10,927
| -54% | -$512K |
|
1995
Advanced Energy
AEIS
$10.9B
| $427K | ﹤0.01% |
+3,910
| New | +$424K |
|
|
YRD
1996
Yiren Digital
YRD
$98.9M
| $427K | ﹤0.01% |
+84,227
| New | +$377K |
|
1997
Tandem Diabetes Care
TNDM
$1.22B
| $424K | ﹤0.01% |
4,795
+646
| +16% | +$60K |
|
1998
Celldex Therapeutics
CLDX
$2.79B
| $423K | ﹤0.01% |
20,580
+8,557
| +71% | +$196K |
|
1999
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.32B
| $422K | ﹤0.01% |
+9,472
| New | +$408K |
|
2000
Rio Tinto
RIO
$149B
| $422K | ﹤0.01% |
5,432
-66,085
| -92% | -$5.42M |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.